Target intelligence / Profile preview

Recipient Cell Surface Proteins

Molecular classification
Receptor (superset, not specific; includes GPCRs, ion channels, etc.), Transporter (in context), Enzyme (in context), Adhesion molecule (in context), Other membrane proteins
01

Overview

Recipient cell surface proteins comprise the entire set of membrane proteins present on the exterior of a cell, which may serve as recognition elements, receptors, adhesion molecules, enzymes, or transporters. These proteins collectively play critical roles in intercellular communication, serving as docking or entry sites for exosomes, extracellular vesicles, pathogens, and a wide variety of signaling molecules[1][3][4][5][7]. The class is essential for processes such as EV-mediated cell–cell communication, immune recognition, and drug targeting, but it is too generic to be regarded as a single target or molecule for pharmacological or mechanistic study. Instead, research and therapeutic interventions typically focus on specific surface proteins (e.g., PD-1 receptor, transferrin receptor, EGFR). In microbiology, "recipient cell surface proteins" may refer to outer membrane proteins or structures enabling conjugation (genetic exchange) between bacteria, such as OmpA, OmpF, or LPS in Gram-negative bacteria[6]. In EV/exosome research, the identity of specific recipient cell surface proteins determines the efficiency, specificity, and outcome of vesicle uptake and downstream signaling[1][3][5][7]. Overall, the term is a useful generic descriptor but is not itself a molecular target and should be replaced with the specific protein or receptor of interest for structured informatics or drug discovery purposes.

02

Biological functions

Mediating uptake of extracellular vesicles (EVs), exosomes, and macromoleculesSignal transductionCell–cell communicationImmune response (including recognition by immune cells)Cell adhesionEndocytosis/macropinocytosisOther (varied, depending on the specific protein)
03

Disease associations

Cancer (as EV communication targets distinguished by disease state)Infection (e.g., as receptors for pathogens or horizontal gene transfer in bacteria)Other (diverse, depending on specific recipient surface proteins)
04

Safety considerations

Off-target effects (therapeutics targeting generic surface proteins may have broad or off-target actions)Immunogenicity (some surface proteins can be recognized as antigens)
05

Biomarkers

Disease- or state-specific recipient surface proteins are often used as biomarkers (e.g., in cancer, infection), but the class as a whole is not a biomarker

Beyond the preview

Go deeper on Recipient Cell Surface Proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Recipient Cell Surface Proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call